AMIT MIRCHANDANI: Open Payments
NPI 1457687378 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 8 payments from 8 companies in 2025. Trend: 2023 $1,414 · 2024 $634 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 1 | $52 |
| Boston Scientific Corporation | 1 | $51 |
| SPR Therapeutics, Inc | 1 | $35 |
| Organogenesis Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Saluda Medical Americas, Inc. | 1 | $18 |
Products named: Intracept, SPRINT PNS System, VIA MATRIX, QULIPTA, PROCLAIM, XTAMPZA, Evoke.
Industry payments across TX — which companies pay providers there.
